VIBRAINT Inc.
VIBRAINT Inc. develops VIBRAINT RehUp, a non-invasive brain-computer interface system that combines AI, robotics, and virtual reality to help patients paralyzed by stroke or spinal cord injury regain motor control. The investigational medical device is currently in clinical research with hospitals and academic centers in North America and Europe.
- Company typePrivate
- Founded2017
- HeadquartersRichmond Hill, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What VIBRAINT Inc. does
VIBRAINT Inc. is a privately held Canadian medical device company developing VIBRAINT RehUp, a non-invasive brain-computer interface (BCI) rehabilitation system that targets patients with severe or total paralysis caused by stroke or spinal cord injury. The system detects patient intention to move through EEG-based BCI signal acquisition, interprets that intent using AI, and executes physical movement of the paralyzed limb via robotics, while a virtual reality layer provides multisensory (visual and task-contextual) feedback designed to help the brain re-master motor control. VIBRAINT RehUp is positioned as an investigational device limited by law to investigational use, with the company framing its addressable population as 120 million immobilized people worldwide, 500,000 new spinal cord injury paralyses annually, and roughly one in six stroke survivors losing motor control.
The firm is headquartered in Richmond Hill, Ontario, operating with a five-person core team (CEO Ilia Borishchev, Clinical Lead Dr. Igor Lavrov, CTO Max Aver, QA/RA Lead Michaela Shaw, CFO Alejandro Vivanco) supplemented by six unpaid volunteer advisors drawn from globally recognized neuroscience and rehabilitation institutions. Its go-to-market is sales-led, targeting clinical research partnerships with hospitals, rehabilitation centers, and trial consortia (CanStroke, University of Calgary, Mayo Clinic, Charité Berlin), and recruiting stroke and SCI patients directly for North American clinical studies. Revenue mechanics are undefined: no pricing model is disclosed, no commercial sales exist, and the product remains investigational, placing VIBRAINT firmly in pre-commercial medtech development.
VIBRAINT has accumulated a broad support ecosystem — clinical (CanStroke, Mayo Clinic, UofT H2i), academic (Calgary, York, McMaster, Anáhuac, OCAD, Charité Berlin), financial (Mitacs, Desjardins), and acceleration (MaRS, Innovation Factory, YEDi, OBIO, Synapse, Venture Lab) — and has been recognized through the BCI Award 2021 nomination, the 2021 Ideation Challenge Judges Prize, a GHP award from 2022 to 2024, and the BCI Award 2024 Pitch-Off. No equity funding rounds, revenue figures, M&A activity, or regulatory approvals are publicly disclosed in the available data.
VIBRAINT Inc. firmographics
Firmographics- Name
- VIBRAINT Inc.
- Legal name
- VIBRAINT Inc.
- Website
- https://vibraint.ai
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- VIBRAINT Inc. develops VIBRAINT RehUp, a non-invasive brain-computer interface system that combines AI, robotics, and virtual reality to help patients paralyzed by stroke or spinal cord injury regain motor control. The investigational medical device is currently in clinical research with hospitals and academic centers in North America and Europe.
- Ownership category
- akta.pro rank
VIBRAINT Inc. industry classification
Industry- Product category
- Neurorehabilitation Medical Devices
- NAICS
- Vocational Rehabilitation Services (62431)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)
Keywords
Where VIBRAINT Inc. is headquartered
LocationHeadquarters
- HQ city
- Richmond Hill
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
VIBRAINT Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Medical Device Sales: VIBRAINT RehUp is described as an investigational device limited by law for investigational use, indicating the product is not yet commercially available. The company appears to be in clinical trial phase with future commercial plans for rehabilitation technology deployment through clinical partnerships and direct patient recruitment for studies.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
VIBRAINT Inc. product offering
Product offeringCore offering
VIBRAINT Inc. develops VIBRAINT RehUp, a brain-controlled rehabilitation system that combines a non-invasive brain-computer interface (BCI) to detect a paralyzed patient's intention to move, AI and robotics to physically execute the movement, and virtual reality (VR) to provide multisensory feedback that helps the brain re-master motor control. The product is currently an investigational device limited to clinical trial use, targeting patients with severe paralysis from stroke or spinal cord injury.
Product overview
VIBRAINT Inc. offers a single unified product called VIBRAINT RehUp, which is a groundbreaking brain-controlled rehabilitation system. The system combines a non-invasive brain-computer interface to detect patient intention, artificial intelligence and robotics to execute physical movements, and virtual reality to provide visual feedback that tricks the brain into believing it fully controls the action. This multisensory approach creates an effective rehabilitation experience for patients with paralysis from stroke or spinal cord injury.
Differentiator
Problem solved
Functional benefit
Brands
- VIBRAINT RehUp: Brain-controlled rehabilitation system combining non-invasive brain-computer interface (BCI), AI, robotics, and virtual reality (VR) to help paralyzed patients regain motor control.
Products and services
- VIBRAINT RehUp A brain-computer interface (BCI) rehabilitation system that detects a paralyzed patient's intention to move through neural signals and executes those movements using AI and robotics, while providing multisensory VR feedback so the brain re-learns motor control. It is currently an investigational device limited by law for investigational use, intended for stroke and spinal cord injury patients in clinical trial settings with hospitals, rehabilitation centers, and clinical researchers.
Companies that use VIBRAINT Inc.
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
VIBRAINT Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature1 record
VIBRAINT Inc. partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- CanStroke Recovery Trials PlatformcoreClinical research partnership with the CanStroke Recovery Trials Platform, led by Dr. Sean Dukelow who serves as Chair of the Steering and Executive Committees. Supports clinical validation of VIBRAINT RehUp technology for stroke rehabilitation.
- University of CalgarycoreAcademic partnership with University of Calgary's Department of Clinical Neuroscience. Dr. Sean Dukelow serves as Professor and Medical Director of Stroke Rehabilitation for the Calgary Stroke Program. Focuses on robotic tools for assessment and rehabilitation of stroke and brain injury patients.
- York UniversitycoreResearch partnership with York University. Prof. Lauren E. Sergio holds the York University Research Chair in Brain Health and Gender in Action, is member of Centre for Vision Research, and core member of VISTA and Connected Minds programs.
- McMaster UniversityminorAcademic research partnership for clinical and rehabilitation technology research.
- Anáhuac University of MexicominorInternational academic partnership for neurorehabilitation research collaboration.
- OCAD UniversityminorDesign and innovation partnership with OCAD University for user experience and interface design of rehabilitation technology.
- Charité – Universitätsmedizin BerlincoreInternational research partnership with Dr. Surjo R. Soekadar, Einstein Professor and Germany's first Professor of Clinical Neurotechnology at Charité Berlin. Dr. Soekadar has been studying neural plasticity and developing BCI technologies since 2005.
- MaRS Discovery DistrictcoreAcceleration partnership with MaRS, one of Canada's largest innovation hubs, supporting startup growth and market access.
- University of Toronto Health Innovation Hub (H2i)corePartnership with U of T Health Innovation Hub. Neil D'Cruz, a Senior Coordinating Mentor at H2i, provides mentorship support. Prof. Morris (Mickey) Milner serves as a founding director connection to the hub.
- Innovation FactoryminorOntario-based innovation accelerator providing support. Ing Goping, with 33 years of medical device experience and two successful exits, serves as advisor through this partnership.
- Venture LabminorAcceleration partnership with Venture Lab for startup support and development.
- Ontario Bioscience Innovation Organization (OBIO)minorPartnership with OBIO to support Ontario bioscience innovation and commercialization.
- YEDi (York Entrepreneurship Development institute)minorYEDi accelerates and funds high-growth companies in Ontario, providing entrepreneurship support.
- Synapse Life Science ConsortiumminorPartnership with Synapse Life Science Consortium supporting life science innovation ecosystem.
- Mayo CliniccoreClinical research partnership where Dr. Igor Lavrov, VIBRAINT's Clinical Lead, has been leading research projects since 2017 at Mayo Clinic's Departments of Neurology and Biomedical Engineering, focusing on reorganization of neural circuits in patients with severe motor deficits.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
VIBRAINT Inc. competitors and assessment
Company assessmentDirect peers
- MindMaze: Swiss-based digital neurotherapeutics company combining VR, AI, and gamification for stroke and brain injury rehabilitation. Closest direct competitor to VIBRAINT RehUp due to overlapping VR + AI + neurorehab approach and similar stroke/spinal cord injury target population.
- Tyromotion: Austrian robotic and computer-assisted rehabilitation device maker for upper and lower extremity therapy in stroke and neuro patients. Comparable as a robotics-driven neurorehabilitation medical device competitor with similar clinical positioning.
- Saebo: US-based company offering functional orthoses and rehabilitation devices for stroke survivors and neurological patients. Comparable as a device-based neurorehab company targeting motor recovery in stroke and SCI populations.
- Bionik Laboratories: Robotic rehabilitation technology company with InMotion ARM and InMotion WRIST devices for upper-limb neurologic rehabilitation. Comparable as a robotic neurorehabilitation medical device peer targeting stroke patients.
- Hocoma: Swiss manufacturer of robotic and sensor-based rehabilitation devices (Lokomat, Armeo) for gait and upper-limb therapy. Directly comparable as a robotic neurorehabilitation medical device company serving stroke and spinal cord injury patients.
Emerging players
- Synchron: BCI company developing a minimally invasive stent-electrode implant for paralysis patients. Comparable as a BCI-focused competitor targeting the same paralysis patient population as VIBRAINT, though using an implanted (rather than non-invasive) approach.
- Fourier Intelligence: Shanghai-based rehabilitation robotics company with ArmMotus and other platforms for stroke and neuro rehab. Comparable as a robotic neurorehabilitation device peer with growing global footprint in the same clinical indications.
- Rehabtronics: Canadian-based neuromodulation and rehabilitation technology company (makers of Prelivia, ReactiStim). Comparable as a Canadian neurorehab device peer with overlapping focus on neurological motor recovery.
Broad incumbents
- Neuralink: Elon Musk-backed BCI company developing high-bandwidth brain implants for paralysis and other neurological conditions. Comparable as the most high-profile BCI competitor addressing paralysis, with vastly greater capital but an invasive (implant) approach rather than VIBRAINT's non-invasive EEG-based method.
- Ekso Bionics: Public wearable exoskeleton and robotic rehabilitation company serving stroke, spinal cord injury, and multiple sclerosis patients. Comparable as a broader, publicly-listed robotic neurorehab incumbent with adjacent technology and overlapping indications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
VIBRAINT Inc. social profiles
Digital presenceVIBRAINT Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
VIBRAINT Inc. leadership team
Management profileNumber of profiles
Profiles5 records
VIBRAINT Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VIBRAINT Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VIBRAINT Inc.
What does VIBRAINT Inc. do?
VIBRAINT Inc. develops VIBRAINT RehUp, a brain-controlled rehabilitation system that combines a non-invasive brain-computer interface (BCI) to detect a paralyzed patient's intention to move, AI and robotics to physically execute the movement, and virtual reality (VR) to provide multisensory feedback that helps the brain re-master motor control. The product is currently an investigational device limited to clinical trial use, targeting patients with severe paralysis from stroke or spinal cord injury.
Is VIBRAINT Inc. a public or private company?
VIBRAINT Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was VIBRAINT Inc. founded?
VIBRAINT Inc. was founded in 2017. It employs 1 to 10 people.
Where is VIBRAINT Inc. based?
VIBRAINT Inc. is headquartered in Richmond Hill, Canada, in the North America region.
How does VIBRAINT Inc. make money?
One revenue line is on record: medical Device Sales.
Who are VIBRAINT Inc.'s main competitors?
Direct peers on record are MindMaze, Tyromotion, Saebo, Bionik Laboratories and Hocoma. Emerging players are Synchron, Fourier Intelligence and Rehabtronics. Broad incumbents are Neuralink and Ekso Bionics.
Does VIBRAINT Inc. have an API?
No public API is recorded for VIBRAINT Inc..
What industry is VIBRAINT Inc. in?
VIBRAINT Inc.'s product category is Neurorehabilitation Medical Devices. Its primary akta.pro industry code is HSADAIAC, Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS). Its NAICS code is 62431 and its SIC code is 3845.